Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX0W9Q
|
||||
| Drug Name |
6-(4-chlorobenzyl)-7-(3,3-dimethylbutyl)-7H-pyrrolo[2,3-d]pyrimidine-2-carbonitrile
|
||||
| Synonyms |
CHEMBL523336
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C20H21ClN4
|
||||
| Canonical SMILES |
CC(C)(C)CCn1c(Cc2ccc(Cl)cc2)cc3cnc(nc13)C#N
|
||||
| InChI |
InChI=1S/C20H21ClN4/c1-20(2,3)8-9-25-17(10-14-4-6-16(21)7-5-14)11-15-13-23-18(12-22)24-19(15)25/h4-7,11,13H,8-10H2,1-3H3
|
||||
| InChIKey |
YUICXLFAQWTQHG-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.